Buy APL Apollo Tubes; target of Rs 1330: Motilal Oswal
Motilal Oswal is bullish on APL Apollo Tubes recommended buy rating on the stock with a target price of Rs 1330 in its research report dated October 10, 2022. Top 100 Best Sellers Read More
Motilal Oswal is bullish on APL Apollo Tubes recommended buy rating on the stock with a target price of Rs 1330 in its research report dated October 10, 2022. Top 100 Best Sellers Read More
Net Sales are expected to increase by 21 percent Y-o-Y (up 4.5 percent Q-o-Q) to Rs. 34,285.3 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 21 percent Y-o-Y (up 4.5 percent Q-o-Q) to Rs. 34,285.3 crore, according to Prabhudas Lilladher. Top 100 Best Sellers Read More
Net Sales are expected to increase by 21 percent Y-o-Y (up 4.5 percent Q-o-Q) to Rs. 34,285.3 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 19.8 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs. 1,859 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 19.8 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs. 1,859 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 22.5 percent Y-o-Y (up 14.6 percent Q-o-Q) to Rs. 6,886.5 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 80.5 percent Y-o-Y (up 5.8 percent Q-o-Q) to Rs. 791.3 crore, according to Prabhudas Lilladher. Read More Top 100 Best Sellers
Net Sales are expected to increase by 80.5 percent Y-o-Y (up 5.8 percent Q-o-Q) to Rs. 791.3 crore, according to Prabhudas Lilladher. Top 100 Best Sellers Read More
Panacea Biotic shares surged on the bourses-NSE and BSE- after the pharmaceutical firm announced on Monday that it had bagged a long-term supply order from UNICEF and Pan American Health Organisation for supply of its pentavalent vaccine Easyfive-TT. Top 100… और पढ़ें »Panacea Biotec stock spikes on $127.3-million global vaccine orders